nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiatherosclerotic effects of statins: LDL versus non-LDL effects
|
Selwyn, Andrew P. |
|
2007 |
9 |
4 |
p. 281-285 |
artikel |
2 |
Antiplatelet therapy for stroke prevention
|
Hankey, Graeme J. |
|
2007 |
9 |
4 |
p. 312-318 |
artikel |
3 |
Atherosclerosis and cardiovascular risk reduction with PPAR agonists
|
Kuusisto, Johanna |
|
2007 |
9 |
4 |
p. 274-280 |
artikel |
4 |
Atherosclerosis regression: Is low-density lipoprotein or high-density lipoprotein the answer?
|
Nicholls, Stephen J. |
|
2007 |
9 |
4 |
p. 266-273 |
artikel |
5 |
Carotid endarterectomy versus angioplasty/stenting for carotid stenosis
|
Barrett, Kevin M. |
|
2007 |
9 |
4 |
p. 333-340 |
artikel |
6 |
Clinical trials report
|
Liao, James K. |
|
2007 |
9 |
4 |
p. 255-257 |
artikel |
7 |
Clinical trials report
|
Goldstein, Larry B. |
|
2007 |
9 |
4 |
p. 258-260 |
artikel |
8 |
Cryptogenic stroke in patients with patent foramen ovale
|
Saver, Jeffrey L. |
|
2007 |
9 |
4 |
p. 319-325 |
artikel |
9 |
Current management of symptomatic intracranial stenosis: Medical versus endovascular therapy
|
Weigele, John B. |
|
2007 |
9 |
4 |
p. 296-304 |
artikel |
10 |
Diagnosis and management of vascular cognitive impairment
|
Nyenhuis, David L. |
|
2007 |
9 |
4 |
p. 326-332 |
artikel |
11 |
Lipid goals in metabolic syndrome and diabetes
|
Colhoun, Helen M. |
|
2007 |
9 |
4 |
p. 286-295 |
artikel |
12 |
Statins for stroke prevention
|
Goldstein, Larry B. |
|
2007 |
9 |
4 |
p. 305-311 |
artikel |
13 |
The role of myeloperoxidase in HDL oxidation and atherogenesis
|
Heinecke, Jay W. |
|
2007 |
9 |
4 |
p. 249-251 |
artikel |
14 |
The strengths and limitations of the ApoB/ApoA-I ratio to predict the risk of vascular disease: a hegelian analysis
|
Sniderman, Allan D. |
|
2007 |
9 |
4 |
p. 261-265 |
artikel |
15 |
Web alert
|
|
|
2007 |
9 |
4 |
p. 252 |
artikel |